Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: Three cases

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 11, 2013, Pages 1066-1068

  Uguz, Faruk ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

Author keywords

Antidepressants; Mirtazapine; Pregnancy

Indexed keywords

CITALOPRAM; MIRTAZAPINE; SERTRALINE;

ADD ON THERAPY; ADULT; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PRACTICE; DECREASED APPETITE; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; DSM-IV; FEMALE; HAMILTON SCALE; HUMAN; INSOMNIA; LOW DRUG DOSE; MAJOR DEPRESSION; NAUSEA; PANIC; PREGNANT WOMAN; PRIORITY JOURNAL; SYMPTOM;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING DISORDERS; FEMALE; HUMANS; MIANSERIN; NAUSEA; PANIC DISORDER; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84879408799     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.766697     Document Type: Article

References (17)

1. Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnany and the risk of preterm birth, low birth weight, intrauterine growth restriction. Arch Gen Psychiatry 2010;67:1012-24.
2. Bánhidy F, A ́ cs N, Puhó E, Czeizel AE. Association between maternal panic disorders and pregnancy complications and delivery outcomes. Eur J Obstet Gynecol Reprod Biol 2006; 124:47-52. (Pubitemid 43020927)
3. A ́ cs N, Bánhidy F, Horváth-Puhó E, Czeizel AE. Maternal panic disorder and congenital abnormalities: a population-based case-control study. Birth Defetcts Res A Clin Mol Teratol 2006;76: 253-61.
4. Rambelli C, Montagnani MS, Oppo A, et al. Panic disorder as a risk factor for post-partum depression: results from the Perinatal Depression- Research&Screening Unit (PND-ReScU) study. J Affect Disord 2010;122:139-43.
5. Robertson E, Grace S, Wallington T, Stewart DE. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 2004;26:289-95. (Pubitemid 38962393)
6. Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:194.e1-194.e5.
7. ACOG Practice Bulltein. Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008;111:1001-20.
8. Yazc O. After Star-D: treatment resistant depression. Arch Neuropsychiatr 2009;46:61-9.
9. Watanabe N, Omori IM, Nakagawa A, et al. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs 2010;24:35-53.
10. Gentile S. Drug treatment for mood disorders in pregnancy. Curr Opin Psychiatry 2011;24:34-40.
11. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington, D.C: American Psychiatric Press; 1997.
12. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, Welfare publication (ADM) 76-338. Rocville, MD: National Intitute of Mental Health; 1976:218-22.
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;23:56-62.
14. Djulus J, Koren G, Einarson TR, et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry 2006;67:1280-4. (Pubitemid 44439703)
15. Rocha FL, Fuzikawa C, Riera R, Hara C. Combination of antidepressants in the treatment of major depressive disorder. J Clin Psychopharmacol 2012;32:278-81.
16. Schwarzer V, Heep A, Gumbruch U, Rohde A. Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine. Arch Gynecol Obstet 2008;277:67-69. (Pubitemid 350160068)
17. Guclu S, Gol M, Dogan E, Saygili U. Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature. Arch Gynecol Obstet 2005;272:298-300.